Trial Profile
Effects of GLP1 agonist liRAglutiDE in patients with antispychotic-drUgs-associATEd diabetes mellitus
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2019
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GRADUATE
- 09 Feb 2014 New trial record